Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
J ANTIINFECTIVES FOR SYSTEMIC USE
J06 IMMUNE SERA AND IMMUNOGLOBULINS
J06B IMMUNOGLOBULINS
J06BD Antiviral monoclonal antibodies
J06BD07 Casirivimab and imdevimab
D12142 Casirivimab and imdevimab <JP>
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
62 Chemotherapeutics
625 Antivirals
6250 Antivirals
D12142 Casirivimab and imdevimab
Drug groups [BR:br08330]
Antiviral
DG03174 Anti-SARS-CoV-2 agent
D12142 Casirivimab and imdevimab
Drug classes [BR:br08332]
Antiviral
DG03174 Anti-SARS-CoV-2 agent
D12142 Casirivimab and imdevimab
Antimicrobials [BR:br08307]
Antivirals
Entry, fusion or uncoating inhibitor
Coronavirus spike protein
D12142 Casirivimab and imdevimab <JP>
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D12142
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D12142
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D12142